Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study

Laura C. Coates, William Tillett, Maria Antonietta D'Agostino, Proton Rahman, Frank Behrens, Erin L. McDearmon-Blondell, Xianwei Bu, Liang Chen, Mudra Kapoor, Philip G. Conaghan, Philip Mease

Research output: Contribution to journal › Article › peer-review

11 Citations (SciVal)

Fingerprint

Dive into the research topics of 'Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science